Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.34 AUD | +5.64% | +6.17% | -14.54% |
05-09 | Neuren Pharmaceuticals Partner Acadia Pharmaceuticals Posts US DAYBUE Sales of $75.9 Million | MT |
04-24 | Neuren Pharmaceuticals Posts AU$243 Million Cash, Short-Term Investments | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.54% | 1.71B | |
+30.73% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+14.75% | 239B | |
+9.80% | 210B | |
-7.85% | 200B | |
+8.12% | 167B | |
-1.42% | 161B |
- Stock Market
- Equities
- NEU Stock
- News Neuren Pharmaceuticals Limited
- Neuren Pharmaceuticals Completes Recruitment for Phase Two Neurological Trial; Shares Fall 4%